The Best News for HEXO Stock Investors This Christmas

HEXO has halted dilutive equity raises, as the company targets becoming earnings and cash flow positive.

| More on:

Soon after the marijuana firm implemented a revised share consolidation on December 18, HEXO’s (TSX:HEXO)(NYSE:HEXO) stock price rose 3.9% on Tuesday after the cannabis firm released a more reassuring press release on December 22.

The latest news is that the cannabis grower has allowed its base shelf prospectus to lapse this month. Investors in HEXO stock may welcome the news for two solid and bullish reasons. Firstly, the company has halted shareholder dilution. Secondly, management is confident about suppressed cash burn and future profitability outlook.

HEXO halts shareholder dilution

In December 2018, the company filed a prospectus to raise up to $800 million in new equity financing during a 25-month period between November 2018 and December 2020.

HEXO utilized just under a third of the planned equity raising capacity. The company only raised $254.3 million between January 2019 and August 2020. After a successful turnaround strategy, “the company has determined not to file another short-form base shelf prospectus at this time,” the latest press release pointed out.

The company once flirted with the possibility of bankruptcy at one point. Lenders gave management a deadline by which to raise new equity. The stock price was in free fall, and there was no guarantee that the markets will continue to fund the firm. Fortunately, funding was secured just in time.

Management doesn’t see a need for new and dilutive equity financing anymore. At least not in the near term. The executive team is positive on the firm’s balance sheet and cash flow outlook. As noted earlier, the numbers are coming right at HEXO.

The company is on course to generate positive cash flow

Management noted a growing oversupply of marijuana in the Canadian market earlier than peers in 2019. It decided to halt further investment in operations and expansion projects. The company shut down operations at selected production sites, disposed of some, and laid off several employees, as it sought to downsize operations given obtaining market conditions.

The plan to right-size operations has been a successful turnaround strategy so far.

Revenue continues to grow while operating expenses remain contained. Cash flow from operations has been improving throughout 2020, as the company reported ever-improving adjusted EBITDA numbers sequentially for six consecutive quarters. We have seen free cash flow generation improve sequentially over five quarters now.

HEXO quarterly Revenue and Free Cash Flow May 2018-October 2020
HEXO’s net revenue is growing every quarter, and free cash flow is improving sequentially. Source: Koyfin.

The company has made tremendous progress in positioning its brands in Canada. It signed international supply deals and launched new, successful products while retaining market leadership in Quebec.

Analysts expect HEXO to report its first positive cash flow from operations in the third quarter of fiscal 2021. The first positive adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) reading is also expected for fiscal second-quarter 2021 ending January 31, next year.

“We are also progressing on the path of becoming cash-flow positive from our operations,” said HEXO CFO, Trent MacDonald in the December 22nd press release. “In light of our solid financial position, and most notably our excellent liquidity and cash flow position, we do not see the need to conduct further rounds of financing in the near future,” he concluded.

Investor takeaway

Investors are noticing HEXO’s tangible progress made during the year 2020. The numbers look much better, and the outlook is encouraging. However, its stock price hasn’t responded much — yet.

Fool contributor Brian Paradza has no position in any of the stocks mentioned. The Motley Fool recommends HEXO. 

More on Cannabis Stocks

four people hold happy emoji masks
Dividend Stocks

Wary of Mining Companies? A Lower-Risk Way to Get in on the Gold and Silver Surge

Frenco-Nevada (TSX:FNV) stock might be a wiser way to play the run in gold prices this year.

Read more »

Cannabis smoke
Cannabis Stocks

Have Cannabis Stocks Totally Gone Up in Smoke?

Let's dive into whether Canadian cannabis stocks are still investable, and what investors should make of the recent volatility in…

Read more »

Researcher works in hemp field
Cannabis Stocks

1 Undervalued Cannabis Stock to Buy and Hold Over the Next Decade

Green Thumb is a beaten-down cannabis stock that trades at a compelling valuation in September 2025.

Read more »

Researcher works in hemp field
Cannabis Stocks

Pot Stocks Rallied Hard in August: Is There More to Come?

Tilray Brands (TSX:TLRY) and the broad basket of pot stocks could heat up from here.

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Canopy Growth Stock Jumped 30% Last Month: What’s Going on?

Canopy Growth (TSX:WEED) stock is picking up traction again, making it an enticing weed play to buy on strength.

Read more »

A cannabis plant grows.
Cannabis Stocks

These Threats Facing Canopy Growth Stock Could Justify Selling it

Let's dive into whether Canopy Growth (TSX:WEED) is a top stock investors should buy right now after its recent dip…

Read more »

A person holds a small glass jar of marijuana.
Stocks for Beginners

This BioCannabis Firm Could Explode with Product Approval

This cannabis stock used to be a major name, so where does it stand now?

Read more »

Medicinal research is conducted on cannabis.
Stocks for Beginners

This TSX Health-Care Stock Is a Long-Term Buy for Patient Investors

This TSX stock continues to be one of the best long-term opportunities, if you're patient.

Read more »